Nutex Health (NASDAQ:NUTX) Downgraded to Buy Rating by Wall Street Zen

Wall Street Zen downgraded shares of Nutex Health (NASDAQ:NUTX) from a strong-buy rating to a buy rating in a research report released on Saturday.

A number of other analysts have also issued reports on NUTX. Weiss Ratings reiterated a “hold (c-)” rating on shares of Nutex Health in a research note on Wednesday, October 8th. Maxim Group set a $205.00 price target on shares of Nutex Health and gave the stock a “buy” rating in a research note on Tuesday, August 26th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $252.50.

Nutex Health Stock Down 1.9%

Shares of NASDAQ:NUTX opened at $94.83 on Friday. The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26. The firm has a market capitalization of $527.25 million, a PE ratio of 7.98 and a beta of -0.20. The firm’s 50-day moving average is $95.44 and its two-hundred day moving average is $113.13. Nutex Health has a 1 year low of $21.45 and a 1 year high of $184.27.

Hedge Funds Weigh In On Nutex Health

Institutional investors and hedge funds have recently made changes to their positions in the stock. Austin Asset Management Co Inc acquired a new position in shares of Nutex Health during the second quarter worth about $315,000. Goldman Sachs Group Inc. grew its position in shares of Nutex Health by 17.9% during the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock worth $852,000 after buying an additional 2,748 shares in the last quarter. Clear Creek Financial Management LLC acquired a new position in shares of Nutex Health during the second quarter worth about $397,000. American Century Companies Inc. boosted its holdings in Nutex Health by 73.0% in the first quarter. American Century Companies Inc. now owns 74,359 shares of the company’s stock valued at $3,497,000 after purchasing an additional 31,366 shares in the last quarter. Finally, Baader Bank Aktiengesellschaft boosted its holdings in Nutex Health by 64.6% in the first quarter. Baader Bank Aktiengesellschaft now owns 10,700 shares of the company’s stock valued at $503,000 after purchasing an additional 4,200 shares in the last quarter. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.